Collectively, our findings strongly suggest that LINC01260 may play an important role in regulating hepatic lipid metabolism through RXRB regulation and may serve as a potential therapeutic target for NAFLD. This evidence concerns the gene RXRB and metabolic dysfunction-associated steatotic liver disease.